Faculty

Back to Index
Diana Lewez Hanna, MD
Assistant Professor of Clinical Medicine
Medicine
IRD 2020 Zonal Ave Off Campus Los Angeles

Overview

Dr. Hanna's research interests include investigation of predictive and prognostic biomarkers in gastrointestinal malignancies and clinical trial protocol development with Dr. Heinz-Josef Lenz.

Dr. Hanna earned her medical degree from University of California, Davis. She then went on to complete her Hematology/Oncology Fellowship at USC, where she served as Chief Fellow.

Awards

Phi Sigma Honor Society

University of California, Davis: Professionalism of the Year in Internal Medicine Award, 2012

Phi Kappa Phi Honor Society

Division of Oncology, USC: Chief Fellow, 2014-2015

is primary position

Division of Oncology, USC: award conferred by, 2014-2015

start date

Division of Oncology, USC: start date, 2014-2015

University of California, Davis: start date, 2012

Division of Oncology, USC: full name, 2014-2015

University of California, Davis: full name, 2012

full name

University of California, Davis: email address, 2012

Division of Oncology, USC: email address, 2014-2015

email address

person in primary position

University of California, Davis: person in primary position, 2012

Division of Oncology, USC: person in primary position, 2014-2015

Division of Oncology, USC: is primary position, 2014-2015

University of California, Davis: is primary position, 2012

last name

University of California, Davis: last name, 2012

Division of Oncology, USC: last name, 2014-2015

HR job title

University of California, Davis: HR job title, 2012

Division of Oncology, USC: HR job title, 2014-2015

Division of Oncology, USC: Department, 2014-2015

Department

University of California, Davis: Department, 2012

Division of Oncology, USC: Organization, 2014-2015

University of California, Davis: Organization, 2012

Organization

position in department

University of California, Davis: position in department, 2012

Division of Oncology, USC: position in department, 2014-2015

Faculty Rank

University of California, Davis: Faculty Rank, 2012

Division of Oncology, USC: Faculty Rank, 2014-2015

University of California, Davis: sort order, 2012

sort order

Division of Oncology, USC: sort order, 2014-2015

University of California, Davis: Person, 2012

Division of Oncology, USC: Person, 2014-2015

Person

Assistant Professor

Division of Oncology, USC: Assistant Professor, 2014-2015

University of California, Davis: Assistant Professor, 2012

University of California, Davis: award conferred by, 2012

type

Division of Oncology, USC: type, 2014-2015

Division of Oncology, USC: Person ID, 2014-2015

University of California, Davis: Person ID, 2012

Person ID

Division of Oncology, USC: end date, 2014-2015

Division of Oncology, USC: Keck School of Medicine of USC, 2014-2015

Keck School of Medicine of USC

University of California, Davis: Keck School of Medicine of USC, 2012

workplace homepage

University of California, Davis: workplace homepage, 2012

label

University of California, Davis: label, 2012

Division of Oncology, USC: label, 2014-2015

position in organization

University of California, Davis: position in organization, 2012

Division of Oncology, USC: position in organization, 2014-2015

award or honor for

University of California, Davis: award or honor for, 2012

Division of Oncology, USC: award or honor for, 2014-2015

Assistant Professor of Clinical Medicine

University of California, Davis: Assistant Professor of Clinical Medicine, 2012

Division of Oncology, USC: Assistant Professor of Clinical Medicine, 2014-2015

Hanna, Diana

Division of Oncology, USC: Hanna, Diana, 2014-2015

University of California, Davis: Hanna, Diana, 2012

University of California, Davis: Medicine, 2012

Medicine

Division of Oncology, USC: first name, 2014-2015

first name

University of California, Davis: first name, 2012

University of California, Davis: type, 2012

Division of Oncology, USC: Medicine, 2014-2015

Award or Honor Receipt

Division of Oncology, USC: Award or Honor Receipt, 2014-2015

Division of Oncology, USC: has faculty rank, 2014-2015

has faculty rank

University of California, Davis: has faculty rank, 2012

preferred title

University of California, Davis: preferred title, 2012

Division of Oncology, USC: preferred title, 2014-2015

University of California, Davis: Award or Honor Receipt, 2012

Division of Oncology, USC: Agent, 2014-2015

University of California, Davis: Agent, 2012

Agent

Position

Division of Oncology, USC: Position, 2014-2015

University of California, Davis: Position, 2012

Division of Oncology, USC: photo, 2014-2015

photo

University of California, Davis: photo, 2012

Publications

Expression of Genes Involved in Vascular Morphogenesis and Maturation Predicts Efficacy of Bevacizumab-Based Chemotherapy in Patients Undergoing Liver Resection. Mol Cancer Ther. 2016 Nov; 15(11):2814-2821. View in: PubMed

Molecular Pathways: Cachexia Signaling-A Targeted Approach to Cancer Treatment. Clin Cancer Res. 2016 Aug 15; 22(16):3999-4004. View in: PubMed

Novel therapeutics in metastatic colorectal cancer: molecular insights and pharmacogenomic implications. Expert Rev Clin Pharmacol. 2016 Aug; 9(8):1091-108. View in: PubMed

Impact of sex, age, and ethnicity/race on the survival of patients with rectal cancer in the United States from 1988 to 2012. Oncotarget. 2016 Jul 19. View in: PubMed

Prognostic Impact of IL6 Genetic Variants in Patients with Metastatic Colorectal Cancer Treated with Bevacizumab-Based Chemotherapy. Clin Cancer Res. 2016 Jul 1; 22(13):3218-26. View in: PubMed

TWIST1 Polymorphisms Predict Survival in Patients with Metastatic Colorectal Cancer Receiving First-Line Bevacizumab plus Oxaliplatin-Based Chemotherapy. Mol Cancer Ther. 2016 Jun; 15(6):1405-11. View in: PubMed

ESMO / ASCO Recommendations for a Global Curriculum in Medical Oncology Edition 2016. ESMO Open. 2016; 1(5):e000097. View in: PubMed

Cytokeratin-20 and Survivin-Expressing Circulating Tumor Cells Predict Survival in Metastatic Colorectal Cancer Patients by a Combined Immunomagnetic qRT-PCR Approach. Mol Cancer Ther. 2015 Oct; 14(10):2401-8. View in: PubMed

Distinct gene expression profiles of proximal and distal colorectal cancer: implications for cytotoxic and targeted therapy. Pharmacogenomics J. 2015 Aug; 15(4):354-62. View in: PubMed

Impact of sex on the survival of patients with hepatocellular carcinoma: A Surveillance, Epidemiology, and End Results analysis. Cancer. 2014 Dec 1; 120(23):3707-16. View in: PubMed

Plastin polymorphisms predict gender- and stage-specific colon cancer recurrence after adjuvant chemotherapy. Mol Cancer Ther. 2014 Feb; 13(2):528-39. View in: PubMed

Biomolecular markers of cancer-associated thromboembolism. Crit Rev Oncol Hematol. 2013 Oct; 88(1):19-29. View in: PubMed

Powered bySC CTSI